Your browser doesn't support javascript.
loading
Hormonal methods for emergency contraception.
Li, Raymond Hang Wun; Lo, Sue Seen Tsing; Cameron, Sharon Tracey.
Affiliation
  • Li RHW; Department of Obstetrics and Gynaecology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong; The Family Planning Association of Hong Kong, 10th Floor, 130 Hennessy Road, Wan Chai, Hong Kong. Electronic address: raymondli@hku.hk.
  • Lo SST; Department of Obstetrics and Gynaecology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong; The Family Planning Association of Hong Kong, 10th Floor, 130 Hennessy Road, Wan Chai, Hong Kong. Electronic address: stlo@famplan.org.hk.
  • Cameron ST; Chalmers Sexual Health Centre, NHS Lothian, 2a Chalmers St, Edinburgh, EH3 9ES, United Kingdom; Centre for Reproductive Health, The University of Edinburgh, Edinburgh BioQuarter, Edinburgh, EH16 4UU, United Kingdom. Electronic address: sharon.cameron@ed.ac.uk.
Best Pract Res Clin Obstet Gynaecol ; 97: 102550, 2024 Sep 03.
Article in En | MEDLINE | ID: mdl-39243521
ABSTRACT
The World Health Organization includes oral emergency contraception (EC) in the list of essential medicines. Ulipristal acetate (UPA) and levonorgestrel (LNG) are the recommended oral methods. UPA has superior efficacy and a comparable side effect profile compared with LNG. Both work by inhibiting or delaying ovulation, so that sperm present in the reproductive tract will have lost their fertilising ability by the time the oocyte is eventually released. Neither LNG nor UPA at the EC doses have significant effects on the endometrium and are unable to prevent implantation. Mifepristone can also be used for EC but its availability is limited to few countries. LNG is less effective in women with a body mass index over 26 kg/m2 or weight over 70 kg. Hormonal contraception can be quickstarted immediately following LNG, or five days following UPA. LNG-releasing intrauterine devices and cyclo-oxygenase inhibitors are promising options for EC to be further studied.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Best Pract Res Clin Obstet Gynaecol Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2024 Document type: Article Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Best Pract Res Clin Obstet Gynaecol Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2024 Document type: Article Country of publication: Países Bajos